Prognostic value of Holter monitoring in congestive heart failure

Cardiology Journal

Volumn 15, Issue 4, 2008, Pages 313-323

  Cygankiewicz, Iwona ^a,b   Zareba, Wojciech ^b   de Luna, Antoni Bayes ^c  

^a Department of Electrocardiology   (Poland)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CATALAN INSTITUTE OF CARDIOVASCULAR SCIENCES   (Spain)

Author keywords

Congestive heart failure; Heart rate turbulence; Heart rate variability; Holter monitoring; Repolarization dynamics; Risk stratification

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AMBULATORY MONITORING; CONGESTIVE HEART FAILURE; DISEASE COURSE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART RHYTHM; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MORTALITY; PROGNOSIS; QT INTERVAL; REVIEW; RR INTERVAL; SINUS NODE CONDUCTION VELOCITY; SURVIVAL RATE; AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; MALE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; SURVIVAL;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 55249124582     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. The Task Force for the Diagnosis and the Treatment of Congestive Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J, 2005; 26: 1115-1140.
2. Rywik TM, Zielinski T, Piotrowski W, Leszek P, Wilkins A, Korewicki J. Heart failure patients from hospital settins in Poland: population characteristics-and treatment patterns, a multicenter retrospective study. Cardiol J, 2008; 15: 169-180.
3. Hogg K, Swedberg K, McMuray J. Heart failure with preserved left ventricular function. Epidemiology, clinical characteristics and prognosis. J Am Coll Cardiol, 2004; 43: 317-327.
4. MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention Trial in congestive heart failure (MERIT-HF). Lancet, 1999; 353: 2001-2007.
5. Carson P, Anand I, O'Connor C et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defbrillator Therapies in Heart Failure (COMPANION) Trial. J Am Coll Cardiol, 2005; 46: 2329-2334.
6. Frenneaux MP. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart, 2004; 90: 1248-1255.
7. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Beanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA, 1994; 271: 840-844.
8. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure:epidemioiogy, pathophysiology ad rationale for therapy. Am J Cardiol, 2003; 91: 2D-8D.
9. Ehrlich JR, Narrel S, Hohnloser SH. Atrial fibrillation and congestive heart failure: specific considerations at intersection at two common and important cardiac disease sets. J Cardiovasc Electrophysiol, 2002; 13: 399-405.
10. Wang TJ, Larson MG, Levy D et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation, 2003; 107: 2920-2925.
11. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillatian on prognosis in mild to moderate heart failure: the V-Heft studies. Circulation, 1993; 87 (suppl VI): VI102-VI110.
12. Crijns HJ, Tjeerdsma G, de Kam PJ et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J, 2000; 21: 1238-1245.
13. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomtic left ventricular dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol, 1998; 32: 695-703.
14. Swedberg K, Olsson LG, Charlesworth A et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J, 2005; 26: 1303-1308.
15. Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ; MADITII Investigators. Implantable cardioverter defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm, 2006; 3: 631-637.
16. Schoonderwoerd BA, Van Gelder IC, van Veldhuisen DJ et al. Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol, 2001; 12: 1404-1410.
17. Grzybczak R, Nessler J, Piwowarska W. Atrial fibrillation as a prognostic factor in patients with systolic heart failure. Folia Cardiol, 2006; 13: 503-510.
18. Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail, 2004; 6: 421-426.
19. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atial fibrillation in advanced heart failure. A study of 390 patients. Circulation, 1991; 4: 40-48.
20. Koitabashi T, Inomata T, Niwano S et al. Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J, 2005; 69: 823-830.
21. Fuster V, Rydén LE, Cannom DS et al American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006; 114: e257-e354.
22. Melenovsky V, Hay I, Fetics BJ et al. Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. Eur Heart J, 2005; 26: 705-711.
23. Rienstra M, Van Gelder IC, Van den Berg MP, Boosmsma F, Hillege HL, Van Veldhuisen DJ. A comparison of low versus high heart rate in patients with atrial fibrillation and advanced heart failure: effects on clinical, profile, neurohormones and survival. Int J Cardiol, 2006; 109: 95-100.
24. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol, 2005; 45: 1654-1664.
25. Mazza A, Tikhonoff V, Casiglia E, Pessina AC. Predictors of congestive heart failure mortality in elderly people from the general population. Int Heart J, 2005; 46: 419-431.
26. Gullestad L, Wikstrand J, Deedwania P et al. MERIT-HF Study Group. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol, 2005; 45: 252-259.
27. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J, 2002; 23: 1861-1866.
28. Kjekhus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J, 1999 (suppl H): H64-H69.
29. Fox K, Borer JS, Camm AJ et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol, 2007: 50: 823-830.
30. Lechat P, Escolano S, Golmard JL et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation, 1997; 96: 2197-2205.
31. Lechat P, Hulot JS, Escolano S et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation, 2001; 103: 1428-1433.
32. Madsen BK, Rasmussen V, Hansen JF. Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography. Int J Cardiol, 1997; 58: 151-162.
33. Baker RL, Koeling TM. Prognostic value of ambulatory electrocardiography monitoring in patients with dilated cardiomyopathy. J Electrocardiol, 2005; 38: 64-68.
34. Singh SN, Carson PE, Fisher SG. Nonsustained ventricular tachycardia in severe heart failure. Circulation, 1997; 97: 3794-3795.
35. Wilson JR, Schwartz JS, Sutton MSJ et al. Prognosis in severe heart failure: relation to hemodynamic measures and ventricular ectopic activity. J Am Coll Cardiol, 1983; 2: 403-410.
36. Chacco CS, Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance and efectiveness of anti-arrhythmic therapy. Am Heart J, 1985; 109: 497-504.
37. Gradman A, Deedwania P, Cody R et al. for the Captopril-Digoxin Study Group. Predictors of total mortality and sudden death in mild-to moderate heart failure. J Am Coll Cardiol, 1989; 14: 564-570.
38. Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. Circulation, 1993; 87 (suppl 6): VI49-VI55.
39. Doval HC, Nul DR, Grancelli HO et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation, 1996; 96: 3198-3208.
40. Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol, 1998; 32: 942-947.
41. Grimm W, Christ M, Maisch B. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol, 2005; 28 (suppl 1): S207-S210.
42. Chen X, Shenasa M, Borggrefe M et al. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: inducibility and prognostic value in 102 patients. Eur Heart J, 1994: 15: 76-82.
43. Moss AJ, Greenberg H, Case RB et al. Multicenter Automatic Defibrllator Implantation Trial II (MADIT-II) Research Group. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation, 2004; 110: 3760-3765.
44. Casolo G, Balli E, Taddei T, Amuhasi J, Gorc C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol, 1989; 64: 1162-1167.
45. Arora R, Krummerman A, Vijayaraman P et al. Heart rate variability and diastolic heart failure. Pacing Clin Electrophysiol, 2004; 27: 299-303.
46. Guzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J, 1995; 16: 1100-1107.
47. Heart rate variability. Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation, 1996; 93: 1043-1065.
48. Binder T, Frey B, Porenta G et al. Prognostic value of heart rate variability in patints awaiting cardiac transplantation. PACE, 1992; 15: 2215-2220.
49. Nolan J, Batin PD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-Heart). Circulation, 1998; 98: 1510-1516.
50. Ponikowski P, Anker SD, Chua TP et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol, 1997; 79: 1645-1650.
51. Boveda S, Galinier M, Pathak A et al. Prognostic value of heart rate variability in time domain analysis in congestive heart failure patients. J Interv Card Electrophysiol, 2001; 5: 181-187.
52. Galinier M, Pathak A, Fourcade J et al. Depressed low frequency power of heart rate variability as an independent predictor of sudden death in chronic heart failure. Eur Heart J, 2000; 21: 475-482.
53. Bilchick KC, Fetics B, Djoukeng R et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans affairs survival trial of antiarrhythmic therapy in congestive heart failure). Am J Cardiol, 2002; 90: 24-28.
54. Yi G, Goldman JH, Keeling PJ, Reardon M, McKenna WJ, Malik M. Heart rate variability inidiopathic dilated cardiomyopahy: relation to disease severity and prognosis. Heart, 1997; 77: 108-114.
55. La Rovere MT, Pinna GD, Maestri R et al. Short-term heart rate variability strongly predicts sudden death in chronic heart failure. Circulation, 2003; 107: 565-570.
56. Hadase M, Azuma A, Zen K et al. Very low frequency power of heart rate variability is a powerful predictr of clinical prognosis in patients with congestive heart failure. Circ J, 2004; 68: 343-347.
57. Guzetti S, La Rovere MT, Pinna GD et al. Different spectral components of 24 h heart rate variability are related to different modes of death in congestive heart failure. Eur Heart J, 2005; 26: 357-362.
58. Guzzetti S, Mezzetti S, Magatelli R et al. Linear and non-linear 24 h heart rate variability in chronic heart failure. Auton Neurosci, 2000; 86: 114-119.
59. Makikallio TH, Huikuri HV, Hintze U et al.; DIAMOND Study Group (Danish Investigations of Arrhythmia and Mortality ON Dofetilide) Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol, 2001; 87: 178-182.
60. Maestri R, Pinna GD, Accardo A et al. Nonlinear indices of heart rate variability in chronic heart failure patients: redundancy and comparative clinical value. J Cardiovasc Electrophysiol, 2007; 18: 425-433.
61. Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic ilated cardiomyopathy. J Am Coll Cardiol, 1999; 33: 1203-1207.
62. Schmidt G, Malik M, Barthel P et al. Heart rate turbulence after ventricular premature beats as a predictor of mortality after myocardial infarction. Lancet, 1999; 353: 1360-1396.
63. Ghuran A, Reid F, La Rovere MT et al. Heart rate turbulence - based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy). Am J Cardiol, 2002; 89: 184-190.
64. Barthel P, Schneider R, Bauer A et al. Risk stratification after acute myocardial infarction by heart rate turbulence. Circulation, 2003; 108: 1221-1226.
65. Cygankiewicz I, Zareba W. Heart rate turbulence - an overview of methods and applications. Folia Cardiol, 2006; 13: 359-368.
66. Koyama J, Watanabe J, Yamada A et al. Evaluation of heart rate turbulence as a new prognostic marker in patients with chronic heart failure. Circ J, 2002; 66: 902-907.
67. Grimm W, Sharkova I, Christ M, Müller HH, Schmidt G, Maisch B. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol, 2003; 14: 819-824.
68. Moore RK, Groves DG, Barlow PE et al. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure. Eur J Heart Fail, 2006; 8: 585-590.
69. Cygankiewicz I, Zareba W, Vazquez R et al. Relation of heart rate turbulence to severity of heart failure. Am J Cardiol, 2006; 98: 1635-1640.
70. Kawasaki T, Azuma A, Asada S et al. Heart rate turbulence and clinical prognosis in hypertrophic cardiomyopathy and myocardial infarction. Circ J, 2003; 67: 601-604.
71. Mrowka R, Persson PB, Theres H, Patzak A. Blunted arterial baroreflex causes "pathological heart rate turbulence. Am J Physiol Regulatory Integrative Comp Physiol, 2000; 279: R1171-R1175.
72. Lin LY, Lai LP, Lin JL et al. Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis. J Cardiovasc Electrophysiol, 2002; 13: 427-431.
73. Cygankiewicz I, Zareba W, Vazquez R et al. on behalf of MUSIC Investigators. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm, 2008 (in press).
74. Klingenheben T, Ptaszynski P, Hohnloser SH. Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated cardiomyopathy. J Electrocardiol, 2008 (in press).
75. Brooksby P, Batin PD, Nolan J et al. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. Eur Heart J, 1999; 20: 1335-1341.
76. Baar CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet, 1994; 343: 327-329.
77. Fauchier L, Douglas J, Babuty D, Consay P, Fauchier JPO. QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluation. Eur J Heart Fail, 2005; 2: 277-282.
78. Kearney MT, Fox KAA, Lee AJ et al. Increased QT dispersion predicted increased risk of mortaility in patients with mild-to - moderate heart failure form UK-Heart Study. Heart, 2004; 90: 1137-1143.
79. Gang Y, Ono T, Hnatkova K et al. ELITE II investigators.QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy. Pacing Clin Electrophysiol, 2003; 26(1 Pt 2): 394-400.
80. Merri M, Alberti M, Moss AJ. Dynamic analysis of ventricular repolarization duration from 24 hour Holter recordings. IEEE Trans Biomed Eng, 1993; 40: 1219-1225.
81. Homs E, Marti V, Offndo J et al. Automatic measurement of corrected QT interval in Holter recordings: comparison of its dynamic behaviour in patients after myocardial infarction with and without life threatening arrhythmias. Am Heart J, 1997; 134: 181-187.
82. Jensen BT, Abildstrom SZ, Larroude CE et al. QT dynamics in risk stratification after myocardial infarction. Heart Rhythm, 2005; 2: 357-364.
83. Alonso JL, Martinez P, Vallverdu M et al. Dynamics of ventricular repolarization in patients with dilated cardiomyopathy versus healthy subjects. Ann Noninvasive Electrocardiol, 2005; 10: 121-128.
84. Chevalier P, Burri H, Adeleine P et al. QT dynamicity and sudden death after myocardial infarction: results of long term follow up study. J Cardiovasc Electrophysiol, 2002; 14: 227-233.
85. Faber TS, Grom A, Schopflin M, Brunner M, Bode C, Zehender M. Beat-to-beat assessment of QT/RR ratio in severe heart failure and overt myocardia ischemia: a measure of electrical integrity in diseased hearts. Pacing Clin Electrophysiol, 2003; 26: 836-842.
86. Pellerin D, Maison Blanche P, Extramiana F et al. Autonomic influences on ventricular repolarization in congestive heart failure. J Electrocadiol, 2001; 34: 35-40.
87. Merri M, Moss AJ, Benhorin J, Locati EH, Alberti M, Badilini F. Relation between ventricular repolarization duration and cardiac cycle lenght during 24 hour Holter recordings. Findings in normal patients and patients with long QT syndrome. Circulation, 1992; 85: 1816-1821.
88. Pathak A, Curnier D, Fourcade J et al. QT dynamicity: a prognostic factor for sudden death in chronic heart failure. Eur J Heart Fail, 2005; 7: 269-275.
89. Watanabe E, Arakawa T, Uchiyama T et al. Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure. Heart Rhythm, 2007; 4: 999-1005.
90. Iacoviello M, Forleo C, Guida P et al. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol, 2007; 50: 225-231.
91. Cygankiewicz I, Zareba W, Vazquez R et al. on behalf of MUSIC Investigators. Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure. J Cardiovasc Electrophyiol, 2008 (in press).
92. Zareba W, Bayes de Luna A. QT dynamics and variability. Ann Noninvasive Electrocardiol, 2005; 10: 256-262.
93. Berger RD, Kasper EK, Baughman KL, Marban E, Calkins H, Tomaselli GF. Beat-to-beat QT interval variability. Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation, 1997; 96: 1557-1565.
94. Piccirillo G, Magri D, Matera S et al. QT variability strongly predicts sudden cardiac death In asymptomatic subjects with mild or moderate left ventricular dysfunction: a prospective study. Eur Heart J, 2007; 28: 1344-1350.